Capnography Devices Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Component (OEM Modules, Others), By Application (Emergency Medicine, Pain Medicine, Procedural Sedation, Critical Care, Others), By Technology (Mainstream, Sidestream, Microstream), By Type (Hand-Held, Stand-Alone, Multi-Parameter), By End User (Hospitals, Ambulatory Care Centers, Others), By Region & Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 684.62 Million
CAGR (2026-2031)	10.22%
Fastest Growing Segment	Sidestream
Largest Market	North America
Market Size (2031)	USD 1227.47 Million

Market Overview

The Global Capnography Devices Market will grow from USD 684.62 Million in 2025 to USD 1227.47 Million by 2031 at a 10.22% CAGR. Capnography devices are noninvasive diagnostic tools used to measure the concentration of carbon dioxide in exhaled breath to assess patient ventilation and circulatory status in clinical environments. The market is fundamentally driven by the escalating global prevalence of chronic respiratory diseases and the rigorous enforcement of medical safety protocols that mandate continuous carbon dioxide monitoring during anesthesia and sedation procedures. According to the Society of Critical Care Medicine, in 2024, sepsis was reported to affect approximately 50 million people worldwide, a statistic that underscores the critical necessity for reliable physiological monitoring in intensive care units to manage such high risk conditions effectively.

However, a notable challenge impeding broader market expansion is the substantial capital investment required for advanced capnography equipment which creates a barrier to entry for healthcare facilities in financially constrained regions. This economic obstacle is often compounded by a scarcity of trained medical professionals capable of accurately interpreting capnographic data, effectively limiting the widespread integration of these lifesaving technologies into healthcare systems with restricted budgets.

Key Market Drivers

Stringent regulatory mandates regarding anesthesia and procedural sedation safety serve as a primary catalyst for the market. Regulatory bodies and professional societies globally are enforcing rigorous guidelines that necessitate continuous monitoring of end-tidal carbon dioxide to prevent respiratory adverse events during surgical interventions. These protocols are essential for mitigating risks associated with opioid-induced respiratory depression and ensuring patient stability. According to The Joint Commission, July 2024, in the 'Sentinel Event Data 2023 Annual Review', the organization reviewed 1,411 sentinel events, a figure that highlights the persistent need for enhanced physiological monitoring standards in accredited healthcare organizations to reduce preventable harm.

The rising prevalence of chronic respiratory and airway disorders further accelerates the demand for advanced capnography solutions. Healthcare providers are increasingly relying on capnometers for long-term assessment and acute management of debilitating lung conditions. According to the World Health Organization, March 2024, in the 'Chronic Obstructive Pulmonary Disease' fact sheet, this condition is the third leading cause of death globally, accounting for 3.23 million deaths annually, creating a sustained requirement for effective ventilation monitoring tools. Additionally, the utility of these devices in emergency cardiovascular care continues to expand. According to the American Heart Association, January 2024, in the 'Heart Disease and Stroke Statistics—2024 Update', there are more than 356,000 out-of-hospital cardiac arrests annually in the United States, a statistic that reinforces the critical role of capnography in monitoring resuscitation quality.

Download Free Sample Report

Key Market Challenges

The substantial capital investment required for advanced capnography equipment constitutes a primary barrier impeding the growth of the Global Capnography Devices Market. This financial constraint prevents healthcare facilities in developing and budget-restricted regions from procuring essential monitoring systems, thereby limiting the market’s geographic reach. When hospitals cannot afford the initial acquisition costs, manufacturers face a saturated market in developed nations while being unable to penetrate high-potential emerging economies, directly stifling revenue expansion.

Furthermore, this economic challenge is deeply intertwined with a lack of specialized personnel required to operate such devices. The market cannot expand into regions that lack both the funding for devices and the skilled labor to interpret the data they generate. According to the World Federation of Societies of Anaesthesiologists, in September 2024, there was a gap of 100% between the clinical need for capnography and its actual availability in low-resource settings due to these specific resource constraints. This statistic highlights how financial and workforce deficits leave vast global populations unserved, creating a rigid ceiling on market volume and adoption rates globally.

Key Market Trends

The Convergence with Multi-Parameter Patient Monitoring Ecosystems is rapidly reshaping the competitive landscape as healthcare providers prioritize consolidated platforms over standalone devices to enhance clinical workflow efficiency. This trend is characterized by the integration of capnography modules into advanced multi-parameter monitors that simultaneously track hemodynamics, oxygen saturation, and brain function, thereby reducing bedside clutter and providing a holistic view of patient stability. By embedding respiratory mechanics directly into broader physiological monitoring hubs, manufacturers are addressing the demand for comprehensive, high-acuity surveillance solutions that support complex decision-making in operating rooms and intensive care units. The market traction of this integrated approach is evident in the performance of key industry players who have successfully bundled these technologies. According to Masimo Corporation, June 2024, in the 'Investor Presentation', consumable revenues for the company's high-growth technology categories, which include capnography and gas monitoring alongside rainbow and brain monitoring, have grown more than 20% per year, reflecting the robust adoption of these unified diagnostic ecosystems.

Simultaneously, the Incorporation of Wireless Connectivity for Electronic Health Record Integration is driving significant upgrades in monitoring infrastructure, moving the market beyond simple bedside visualization to networked data intelligence. Hospitals are increasingly investing in connected capnography solutions that automatically transmit real-time end-tidal carbon dioxide values to central stations and electronic medical records, mitigating documentation errors and enabling remote patient surveillance. This digital transformation allows for immediate detection of respiratory depression across disparate hospital wards, aligning with the broader push towards interoperable smart hospitals and the Internet of Medical Things (IoMT). The financial impact of this shift towards digitally enabled care is substantial, as healthcare systems allocate capital towards updated, network-ready fleets. According to Royal Philips, January 2024, in the 'Fourth Quarter and Annual Results 2023', comparable sales in the Connected Care business increased by 5% for the full year, a performance primarily driven by double-digit growth in the Monitoring segment, underscoring the critical value placed on networked patient supervision technologies.

Segmental Insights

The Sidestream segment is identified as the fastest growing category in the Global Capnography Devices Market due to its operational suitability for non-intubated patients. This technology samples exhaled gas through a small tube, allowing for effective monitoring during procedural sedation and emergency care where endotracheal tubes are not utilized. The market expansion is further supported by safety guidelines from the American Society of Anesthesiologists, which recommend continuous monitoring of ventilation during moderate sedation. Consequently, healthcare providers are increasingly adopting sidestream modules for their ability to accommodate diverse clinical settings outside traditional operating theaters.

Regional Insights

North America maintains a leading position in the global capnography devices market due to strong regulatory support and established clinical standards. The American Society of Anesthesiologists mandates the use of capnography during moderate to deep sedation, which compels hospitals to integrate these monitoring systems. Additionally, the American Heart Association recommends waveform capnography for verifying endotracheal tube placement and monitoring CPR quality. These guidelines, combined with favorable reimbursement policies and a focus on patient safety in critical care environments, ensure the widespread utilization of capnography solutions across the United States and Canada.

Recent Developments

• In September 2025, Masimo Corporation and Royal Philips announced a renewal and expansion of their partnership to integrate additional monitoring technologies into Philips' multi-parameter patient monitors. The agreement facilitated the incorporation of Masimo’s NomoLine capnography and other advanced measurements into a broader range of Philips' bedside and transport monitors. This collaboration was designed to accelerate the adoption of continuous respiratory and ventilation monitoring across various care continuums, ensuring that clinicians have access to versatile and noninvasive diagnostic technologies for improved patient safety and outcomes.
• In July 2025, Koninklijke Philips N.V. deepened its long-standing collaboration with Medtronic to expand access to advanced patient monitoring solutions. The multi-year agreement focused on integrating Medtronic’s Microstream capnography technology and other patient monitoring capabilities directly into Philips’ patient monitoring systems. This partnership aimed to bundle essential consumables and validated technologies, such as sedation monitoring tools, to streamline procurement and improve clinical workflows in North America. The collaboration reinforced the market presence of Microstream technology as a standard for continuous CO2 monitoring in critical care and procedural settings.
• In September 2024, Nonin Medical entered into a strategic commercial partnership with Corscience, a manufacturer known for its gas analysis technologies. Through this collaboration, Nonin Medical agreed to promote and distribute Corscience’s capnography (CO2 monitoring) modules and devices in the North American market, enhancing its ability to offer comprehensive respiratory monitoring solutions. In exchange, Corscience agreed to promote Nonin’s pulse oximetry technologies within its global sales channels. This agreement allowed both companies to leverage their respective strengths in noninvasive monitoring to better serve the emergency and clinical care sectors.
• In June 2024, Stryker Corporation announced the launch of the LIFEPAK 35 monitor/defibrillator, a significant advancement in the emergency care segment of the market. This new device was designed with a modern, intuitive platform to streamline workflows for emergency responders and healthcare professionals facing staffing shortages. The LIFEPAK 35 provides real-time access to critical patient data and advanced monitoring capabilities, which are essential for assessing ventilation and respiratory status in high-stress environments. The launch represented a major update to the company's established portfolio of emergency medical response and patient monitoring solutions.

Key Market Players

• Medtronic
• Philips
• Masimo
• Smiths Medical
• GE Healthcare
• Dräger
• Welch Allyn
• Mindray
• Zoll Medical
• Natus Medical

By Component	By Application	By Technology	By Type	By End User	By Region
OEM Modules Others	Emergency Medicine Pain Medicine Procedural Sedation Critical Care Others	Mainstream Sidestream Microstream	Hand-Held Stand-Alone Multi-Parameter	Hospitals Ambulatory Care Centers Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Capnography Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Capnography Devices Market, By Component:

• OEM Modules
• Others

• Capnography Devices Market, By Application:

• Emergency Medicine
• Pain Medicine
• Procedural Sedation
• Critical Care
• Others

• Capnography Devices Market, By Technology:

• Mainstream
• Sidestream
• Microstream

• Capnography Devices Market, By Type:

• Hand-Held
• Stand-Alone
• Multi-Parameter

• Capnography Devices Market, By End User:

• Hospitals
• Ambulatory Care Centers
• Others

• Capnography Devices Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE